nevirapine has been researched along with loviride in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, M; Hanasaki, Y; Ijichi, K; Katsuura, K; Konno, K; Sakai, S; Shirakawa, S; Takayama, H; Watanabe, H; Yamaguchi, K | 1 |
| Andries, K; Arnold, E; Azijn, H; de Béthune, MP; De Clercq, E; Grous, PG; Janssen, PA; Krishnan, S; Kukla, MJ; Ludovici, DW; Pauwels, R | 1 |
| De Corte, BL | 1 |
| Kang, X; Kollman, PA; Kuntz, ID; Wang, J | 1 |
| Baba, M; Makino, M; Nakade, K; Okamoto, M; Yamada, K; Yuasa, S | 1 |
| Boucher, CA; Miller, V; Phair, JP; Staszewski, S | 1 |
| Anné, J; De Clercq, E; Jonckheere, H; Witvrouw, M | 1 |
| Bowers, M | 1 |
2 review(s) available for nevirapine and loviride
| Article | Year |
|---|---|
From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Topics: Anti-HIV Agents; Benzodiazepines; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptase; Imidazoles; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors | 2005 |
Clinical experience with non-nucleoside reverse transcriptase inhibitors.
Topics: Acetamides; Acetophenones; Animals; Anti-HIV Agents; Delavirdine; HIV; HIV Infections; Nevirapine; Nucleosides; Reverse Transcriptase Inhibitors | 1997 |
6 other study(ies) available for nevirapine and loviride
| Article | Year |
|---|---|
Thiadiazole derivatives: highly potent and specific HIV-1 reverse transcriptase inhibitors.
Topics: Antiviral Agents; Cell Line; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Thiadiazoles | 1995 |
Evolution of anti-HIV drug candidates. Part 1: From alpha-anilinophenylacetamide (alpha-APA) to imidoyl thiourea (ITU).
Topics: Acetamides; Acetophenones; Aniline Compounds; Anti-HIV Agents; Drug Design; Drug Evaluation, Preclinical; Drug Stability; HIV Reverse Transcriptase; HIV-1; Imines; Structure-Activity Relationship; Thiourea | 2001 |
Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.
Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics | 2005 |
Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1 infected cells.
Topics: Acetamides; Acetophenones; Cell Line, Transformed; HIV; HIV Core Protein p24; HIV-1; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Uracil; Zidovudine | 1996 |
Lamivudine resistance of HIV type 1 does not delay development of resistance to nonnucleoside HIV type 1-specific reverse transcriptase inhibitors as compared with wild-type HIV type 1.
Topics: Acetamides; Acetophenones; Anti-HIV Agents; Cells, Cultured; Cytopathogenic Effect, Viral; Drug Resistance, Microbial; Genes, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Virus Replication | 1998 |
Non-nucleoside reverse transcriptase inhibitors.
Topics: Acetamides; Acetophenones; Antiviral Agents; Delavirdine; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indoles; Nevirapine; Piperazines; Pyridines; Reverse Transcriptase Inhibitors | 1996 |